Rolvedon

NDC 82497-132 · Assertio Specialty Pharmaceuticals, LLC

Generic nameeflapegrastim-xnst

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)EFLAPEGRASTIM

Strength13.2 mg/.6mL

Pharmacologic classGranulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]

Marketing categoryBLA

Packages

82497-132-01 — .6 mL in 1 SYRINGE, GLASS (82497-132-01)

J1449 — Injection, eflapegrastim-xnst, 0.1 mg Medicare Part B payment limit (ASP + 6%): $38.56

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.